Healio

Treating obesity as a disease: A chronic, relapsing condition requiring comprehensive care

Please provide your email address to receive an email when new articles are posted on . Many clinicians overlook neurohormonal and metabolic adaptations that make weight loss difficult. Obesity ...
News Medical

WHO releases first guideline on the use of GLP-1 therapies for treating obesity

To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO) has released its first guideline on the use of Glucagon-Like ...
clinicaladvisor.com

WHO Conditionally Recommends GLP-1s for Long-Term Obesity Care

The guideline is based on the recognition of obesity as a chronic, relapsing disease that requires lifetime care. The World Health Organization (WHO) has released an evidence-informed guideline on the ...
ascopubs.org

Using Early Biomarker Change and Treatment Adherence to Predict Risk of Relapse Among Patients With Chronic Myeloid Leukemia Who Are in Remission

Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial We analyzed electronic health record data of ...
Healio

Q&A: Managing ‘the biggest triggers’ for chronic hand eczema with Bruce Brod, MD

The cold, dry air of winter brings challenges for those with chronic hand eczema. Chronic hand eczema (CHE), defined as hand ...
Nasdaq

FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment

HOUSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the ...